Status:
public
Videos: (
0
) Documents: (
0
) Comments: (
2
)
Group description
Bio Lab Managers Email Database
Group Videos
No videos have been added jet. You may join this group and add yours now.
Group Documents
No documents have been added jet. You may join this group and add yours now.
News
- BIO CEO Confab Live Blog: Day 2
BIO CEO Confab Live Blog: Day Two NEW YORK (TheStreet) -- Stay here all day for live coverage from the second and final day of the BIO CEO & Investor Conference. The two-day conference, put on by BIO, the biotech industry's main lobbying group, typically spotlights small-cap biotech companies that are often shut out of investor conferences run by large investment banks. ... Click to view a price ... - Karo Bio Terminates the Eprotirome Program
Regulatory News: - BIO CEO Conference Live Blog
2012 BIO CEO & Investor Live Blog NEW YORK (TheStreet) -- The 2012 BIO CEO & Investor Conference kicks off this morning here at the Waldorf-Astoria Hotel. The two-day conference, put on by BIO, the biotech industry's main lobbying group, typically spotlights small-cap biotech companies that are often shut out of investor conferences run by large investment banks. ... Click to view a price quote ... - Karo Bio: Information regarding trading suspension
Regulatory News: - BIO Channel's BIO.com Celebrates Black History Month
NEW YORK, Feb. 6, 2012 /PRNewswire/ -- Coming off its best month ever with over 5mm unique visitors in January, BIO.com, the official site of the BIO Channel, is celebrating Black History Month with all ... - Why Bio-Reference Laboratories' Earnings May Not Be So Hot
All cash flow is not created equal. - Bio-Path Holdings Successfully Completes Second Cohort in Phase I Clinical Trial of Lead Product Candidate Liposomal ...
Bio-Path Holdings, Inc. , a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has completed treatment of the second dosage cohort in the Company’s Phase I clinical trial of its lead product candidate, BP-100-1.01 , which is a systemic treatment for blood cancers including acute myeloid leukemia , chronic myelogenous leukemia ... - DiaMedica to Present at the 14th Annual BIO CEO and Investor Conference
WINNIPEG, MANITOBA-- - DiaMedica Inc. a biopharmaceutical company focused on the development of novel treatments for Type 1 and Type 2 diabetes announced today that Mr. Rick Pauls, DiaMedica's President and Chief Executive Officer, will present at the 2012 BIO CEO & Investor Conference in New York on ... - Investment community to come out in full force at BIO-Europe Spring® 2012
Biopharm is gearing up for BIO-Europe Spring®, EBD Group’s springtime life science partnering conference in Amsterdam March 19–21, 2012 at the Amsterdam RAI Convention Center. BIO-Europe Spring attracts some of the best and brightest biotech companies in the sector, and the venture capital community has realized this opportunity by increasing their presence with more representatives this year. - BIO's 9th Annual World Congress on Industrial Biotechnology and Bioprocessing in Orlando to ...
Scheduled for April 29 to May 2, World Congress on Industrial Biotechnology and Bioprocessing will feature 6 breakout session tracks, and investor sessions that will allow executives to make 25-min presentations on their technology development and business models. Breakout tracks will include Advanced Biofuel Technologies, Algae and Feedstock Crops, Renewable Chemical Platforms and Biobased ...
Posted by: scidata | 29-03-10 | Report Abuse
We have developed European Proteomics
Posted by: scidata | 29-03-10 | Report Abuse
Dear All
We have developed European Proteomics